Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Find generic entry opportunities
Manage your formulary budget
|Title:||Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative|
|Abstract:||The invention relates to oral pharmaceutical compositions comprising a diphosphonic acid derivative and sodium laurylsulfate in the amount of 1.5 to 6% by weight, relative to the diphosphonic compound.|
|Inventor(s):||Fels; Jean-Pierre (Castelnau le lez, FR), Gromenil; Jean-Claude (Montbazin-Poussan, FR), Abramovici; Bernard (Juvignac, FR)|
|Assignee:||Societe Anonyme dite : SANOFI (Paris, FR)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Dosage form;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|France||88 04628||Apr 07, 1988|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.